Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 6
Journal homepage
562
Views
42
CrossRef citations to date
0
Altmetric
Original Article

Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus

Tomonori IshiiDepartment of Clinical Research, Innovation and Education Center, Tohoku University Hospital, Miyagi, Japan; Correspondence[email protected]
View further author information
,
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan; View further author information
,
Atsushi KawakamiDivision of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; View further author information
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan; View further author information
,
Kunihiro IchinoseDivision of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; View further author information
,
Hiroshi FujiiDivision of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, JapanView further author information
,
Yuko ShirotaDivision of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, JapanView further author information
,
Tsuyoshi ShiraiDivision of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, JapanView further author information
,
Yoko FujitaDivision of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, JapanView further author information
,
Ryu WatanabeDivision of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, JapanView further author information
,
Shih-Wei ChiuDepartment of Clinical Research, Innovation and Education Center, Tohoku University Hospital, Miyagi, Japan; View further author information
,
Takuhiro YamaguchiDepartment of Clinical Research, Innovation and Education Center, Tohoku University Hospital, Miyagi, Japan; View further author information
&
Hideo HarigaeDivision of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Miyagi, JapanView further author information
 show all
Pages 986-992 | Received 06 Nov 2017, Accepted 15 Jan 2018, Published online: 15 Feb 2018

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Eugene Krustev, Ann E. Clarke & Megan R.W. Barber. (2023) B cell depletion and inhibition in systemic lupus erythematosus. Expert Review of Clinical Immunology 19:1, pages 55-70.
Read now
Ayse Bag-Ozbek & Joyce S Hui-Yuen. (2021) Emerging B-Cell Therapies in Systemic Lupus Erythematosus. Therapeutics and Clinical Risk Management 17, pages 39-54.
Read now
Ying Ding, Ying Tan, Zhen Qu & Feng Yu. (2020) Renal microvascular lesions in lupus nephritis. Renal Failure 42:1, pages 19-29.
Read now
Nicola Luigi Bragazzi, Abdulla Watad, Giovanni Damiani, Mohammad Adawi, Howard Amital & Yehuda Shoenfeld. (2019) Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature. Expert Review of Molecular Diagnostics 19:11, pages 969-978.
Read now
Stanley C. Xie, Lawrence R. Dick, Alexandra Gould, Stephen Brand & Leann Tilley. (2019) The proteasome as a target for protozoan parasites. Expert Opinion on Therapeutic Targets 23:11, pages 903-914.
Read now

Articles from other publishers (37)

Bihui Tang & Xiao Yang. (2023) Clinical advances in immunotherapy for immune-mediated glomerular diseases. Clinical and Experimental Medicine.
Crossref
Sayali B. Thakare, Paolo Nikolai So, Sonia Rodriguez, Mohamed Hassanein, Edgar Lerma & Nasim Wiegley. (2023) Novel Therapeutics for Management of Lupus Nephritis: What Is Next?. Kidney Medicine 5:8, pages 100688.
Crossref
Renee F. Modica, Akaluck Thatayatikom, Denise H. Bell-Brunson & Melissa E. Elder. (2023) Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases. Clinical Rheumatology 42:7, pages 1965-1979.
Crossref
Carla Sans-Pola, Immaculada Danés, Josep Àngel Bosch, Patricia Marrero-Álvarez, Josefina Cortés & Antònia Agustí. (2023) Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review. Frontiers in Medicine 10.
Crossref
Pawlak-Buś Katarzyna, Schmidt Wiktor, Dudziec Ewa & Leszczyński Piotr. (2023) Current treatment of systemic lupus erythematosus: a clinician's perspective. Rheumatology International 43:8, pages 1395-1407.
Crossref
Julius Lindblom, Daniel Toro-Domínguez, Elena Carnero-Montoro, Lorenzo Beretta, Maria Orietta Borghi, Jessica Castillo, Yvonne Enman, Chandra Mohan, Marta E. Alarcón-Riquelme, Guillermo Barturen & Ioannis Parodis. (2023) Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus. Journal of Autoimmunity 136, pages 103025.
Crossref
Chi Chiu Mok. (2023) Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline. Drugs 83:6, pages 479-496.
Crossref
Daniele Accapezzato, Rosalba Caccavale, Maria Pia Paroli, Chiara Gioia, Bich Lien Nguyen, Luca Spadea & Marino Paroli. (2023) Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. International Journal of Molecular Sciences 24:7, pages 6578.
Crossref
Nikita Kedia, Vincent Theillac, Manuel Paez-Escamilla, Chad Indermill, Denise S. Gallagher, Raphaël Adam, Anne Lise Qu-Knafo, Fatima Amari, Caroline Bottin, Géraldine Chotard, Violaine Caillaux, Maté Strého, Neila Sedira, Emmanuel Héron, Pierre-André Becherel, Bahram Bodaghi, Sarah Mrejen-Uretski, Alain-José Sahel, David Saadoun & Marie-Hélène Errera. (2023) The full range of ophthalmological clinical manifestations in systemic lupus erythematosus. Frontiers in Ophthalmology 2.
Crossref
Michael Alsharkawy, Alice Mason, May Lwin & Christopher J Edwards. (2023) CAR T Cell Therapy: A New Hope for Refractory Lupus?. Rheumatology 2:2, pages 1.
Crossref
Ruyu Yan, Shuang Zhou, Jinuo Wang & Huaxia Yang. (2022) Successful treatment with bortezomib for refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Rheumatology and Immunology Research 3:4, pages 208-210.
Crossref
Mary K. Crow. (2022) Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway. Current Opinion in Pharmacology 67, pages 102291.
Crossref
Leah Arbitman, Richard Furie & Himanshu Vashistha. (2022) B cell-targeted therapies in systemic lupus erythematosus. Journal of Autoimmunity 132, pages 102873.
Crossref
Ioannis Parodis, Mariele Gatto & Christopher Sjöwall. (2022) B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools. Frontiers in Medicine 9.
Crossref
Agner R. Parra Sánchez, Alexandre E. Voskuyl & Ronald F. van Vollenhoven. (2022) Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nature Reviews Rheumatology 18:3, pages 146-157.
Crossref
Sophia Davidson, Chien-Hsiung Yu, Annemarie Steiner, Frédéric Ebstein, Paul J. Baker, Valentina Jarur-Chamy, Katja Hrovat Schaale, Pawat LaohamonthonkulKlara Kong, Dale J. Calleja, Cassandra R. Harapas, Katherine R. BalkaJacob Mitchell, Jacob T. Jackson, Niall D. Geoghegan, Fiona MoghaddasKelly L. Rogers, Katrin D. Mayer-Barber, Adriana A. De Jesus, Dominic De Nardo, Benjamin T. Kile, Anthony J. SadlerM. Cecilia Poli, Elke Krüger, Raphaela Goldbach Mansky & Seth L. Masters. (2022) Protein kinase R is an innate immune sensor of proteotoxic stress via accumulation of cytoplasmic IL-24. Science Immunology 7:68.
Crossref
Georgia-Savina Moysidou & Dimitrios T. Boumpas. 2022. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title]. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title].
Christopher J. Kirk, Tony Muchamuel, Jinhai Wang & R. Andrea Fan. (2021) Discovery and Early Clinical Development of Selective Immunoproteasome Inhibitors. Cells 11:1, pages 9.
Crossref
Hajime Yoshifuji & Kazuyuki Yoshizaki. (2021) Chronic Lymphadenopathy-differential Diagnosis and Discussion on Pathophysiology-.慢性リンパ節腫大疾患―その鑑別と病態考察―. Nihon Naika Gakkai Zasshi 110:10, pages 2278-2285.
Crossref
Tomas Walhelm, Iva Gunnarsson, Rebecca Heijke, Dag Leonard, Estelle Trysberg, Per Eriksson & Christopher Sjöwall. (2021) Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study. Frontiers in Immunology 12.
Crossref
Susan P. Canny & Shaun W. Jackson. (2021) B Cells in Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 47:3, pages 395-413.
Crossref
Ewa Bryl. (2021) B cells as target for immunotherapy in rheumatic diseases – current status. Immunology Letters 236, pages 12-19.
Crossref
Yemil Atisha-Fregoso, Bahtiyar Toz & Betty Diamond. (2021) Meant to B: B cells as a therapeutic target in systemic lupus erythematosus. Journal of Clinical Investigation 131:12.
Crossref
Carl Christoph Goetzke, Frédéric Ebstein & Tilmann Kallinich. (2021) Role of Proteasomes in Inflammation. Journal of Clinical Medicine 10:8, pages 1783.
Crossref
Yvonne Sundström, Ming-Mei Shang, Sudeepta Kumar Panda, Caroline Grönwall, Fredrik Wermeling, Iva Gunnarsson, Ingrid E. Lundberg, Michael Sundström, Per-Johan Jakobsson & Louise Berg. (2021) Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay. Translational Research 229, pages 69-82.
Crossref
Kanae Akita, Ken Yasaka, Tsuyoshi Shirai, Tomonori Ishii, Hideo Harigae & Hiroshi Fujii. (2021) Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus. Frontiers in Immunology 11.
Crossref
J.A. Reynolds & I.N. Bruce. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus 661 671 .
Shereen Oon. 2021. Pathogenesis of Systemic Lupus Erythematosus. Pathogenesis of Systemic Lupus Erythematosus 67 95 .
Lennard OstendorfMarie BurnsPawel DurekGitta Anne HeinzFrederik HeinrichPanagiotis GarantziotisPhilipp EnghardUlrich RichterRobert Biesen, Udo SchneiderFabian KnebelGerd BurmesterAndreas RadbruchHenrik E. MeiMir-Farzin Mashreghi, Falk HiepeTobias Alexander. (2020) Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. New England Journal of Medicine 383:12, pages 1149-1155.
Crossref
Fabio Basta, Federica Fasola, Konstantinos Triantafyllias & Andreas Schwarting. (2020) Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New. Rheumatology and Therapy 7:3, pages 433-446.
Crossref
Ioannis Parodis, Marit Stockfelt & Christopher Sjöwall. (2020) B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice. Frontiers in Medicine 7.
Crossref
Kalliopi Klavdianou, Argyro Lazarini & Antonis Fanouriakis. (2020) Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline. BioDrugs 34:2, pages 133-147.
Crossref
Mei Lan Tan, Shahrul Bariyah Sahul Hamid, Muhammad Asyraf Abduraman & Heng Kean Tan. 2020. Cancer Immunology. Cancer Immunology 307 353 .
Ena Ladi, Christine Everett, Craig E. Stivala, Blake E. Daniels, Matthew R. Durk, Seth F. Harris, Malcolm P. Huestis, Hans E. Purkey, Steven T. Staben, Martin Augustin, Michael Blaesse, Stefan Steinbacher, Celine Eidenschenk, Rajita Pappu & Michael Siu. (2019) Design and Evaluation of Highly Selective Human Immunoproteasome Inhibitors Reveal a Compensatory Process That Preserves Immune Cell Viability. Journal of Medicinal Chemistry 62:15, pages 7032-7041.
Crossref
Eva Schrezenmeier, Sarah Y. Weißenberg, Ana-Luisa Stefanski, Franziska Szelinski, Annika Wiedemann, Andreia C. Lino & Thomas Dörner. (2019) Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations. Current Opinion in Rheumatology 31:2, pages 175-184.
Crossref
Siegfried Kohler, Stefanie Märschenz, Ulrike Grittner, Tobias Alexander, Falk Hiepe & Andreas Meisel. (2019) Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial. BMJ Open 9:1, pages e024523.
Crossref
Tobias Alexander, Qingyu Cheng, Jens Klotsche, Laleh Khodadadi, Aderajew Waka, Robert Biesen, Bimba F. Hoyer, Gerd R. Burmester, Andreas Radbruch & Falk Hiepe. (2018) Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors. European Journal of Immunology 48:9, pages 1573-1579.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.